tiprankstipranks
TipRanksTop Financial ExpertsInsidersGary Stetz

Gary Stetz Insider Profile

4 Followers
Gary Stetz, Interim CEO, Director at Hepion Pharmaceuticals, holds 3.25M shares in Hepion Pharmaceuticals (Ticker: HEPA), holds 134.18K shares in Canton Strategic Holdings (Ticker: CNTN), holds 56.98K shares in BCB Bancorp (Ticker: BCBP). Most recently, Gary Stetz Bought ― shares of Hepion Pharmaceuticals on Aug 12, 2026 for an estimated value of $100.00K.
See the Hottest Stocks Based on Insider Trading >
tipranks
Gary Stetz

Gary Stetz
Hepion Pharmaceuticals (HEPA)
Interim CEO, Director

Ranked #12,909 out of 108,921 Corporate Insiders

Profitable Transactions

43%
6 out of 14 Profitable Transactions

Average Return

+13.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$1M
45.49%
28.17%
26.34%
A breakdown of Gary Stetz's holdings
See the Top Stocks by Insiders

Insider Roles

BCB Bancorp
(BCBP)
Director
Canton Strategic Holdings
(CNTN)
Director
Hepion Pharmaceuticals
(HEPA)
Interim CEO, Director
Roles that Gary Stetz holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Hepion Pharmaceuticals
(HEPA)
Rating:Informative Buy
Date:Aug 12, 2026 - Today
Return:+72.50%
The most profitable trade made by Gary Stetz
See the Latest Stocks Traded by Insiders

Gary Stetz's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HEPA
Hepion Pharmaceuticals
Aug 12, 2026
Interim CEO, Director
Informative Buy
100.00K
$286.00K
BCBP
BCB Bancorp
Mar 14, 2018
Director
Informative Buy
7.90K
$494.01K
CNTN
Canton Strategic Holdings
May 27, 2026
Director
Informative Sell
343.88K
$305.92K
List of latest transactions for each holding click on a transaction to see Gary Stetz's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Gary Stetz insider profile FAQ

What is the percentage of profitable transactions made by Gary Stetz?
The percentage of profitable transactions made by Gary Stetz is 43%.
    What is the average return per transaction made by Gary Stetz?
    The average return per transaction made by Gary Stetz is 13.00%.
      What stocks does Gary Stetz hold?
      Gary Stetz holds: HEPA, BCBP, CNTN stocks.
        What was Gary Stetz’s latest transaction?
        Gary Stetz latest transaction was an Informative Buy of $100.00K.
          What was Gary Stetz's most profitable transaction?
          Gary Stetz’s most profitable transaction was an Informative Buy of HEPA stock on August 12, 2026. The return on the trade was 72.50%.
            What is Gary Stetz's role in Hepion Pharmaceuticals?
            Gary Stetz's role in Hepion Pharmaceuticals is Interim CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.